<?xml version="1.0" encoding="UTF-8"?>
<p>The major mucocutaneous diseases caused by herpes simplex virus (HSV) in humans are well managed by existing antiviral drugs, but neonatal herpes and herpes encephalitis are not.
 <xref ref-type="bibr" rid="b1-dddt-3-289">1</xref> The drug of choice in the latter diseases is intravenous acyclovir (ACV), and an alternative drug for ACV-resistant viruses is foscarnet (phosphonoformate [PFA]), but some mortality still occurs and considerable morbidity remains for survivors.
</p>
